Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × abemaciclib × Plasma cell × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 14 Gynecologic 5 CNS 4 Sarcoma 3 Thoracic 2 Genitourinary 2 Gastrointestinal 2 Tumor-Agnostic 1 Plasma cell 1 Other solid neoplasm 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 102 Lenalidomide 47 Bortezomib 42 Melphalan 39 Calcium Dobesilate 35 Cyclophosphamide 30 pomalidomide 29 carfilzomib 29 daratumumab 20 belantamab mafodotin 18 ixazomib 16 Peripheral Blood Stem Cell Transplantation 16 fludarabine 14 fludarabine phosphate 12 Whole-Body Irradiation 12 Bendamustine Hydrochloride 12 dexamethasone acetate 11 Tacrolimus 11 Filgrastim 11 Prednisone 10 selinexor 9 dexamethasone 21-phosphate 9 auricularum 9 venetoclax 8 iberdomide 8 Mycophenolic Acid 7 Granulocyte Colony-Stimulating Factor 7 Cyclosporine 7 Busulfan 7 liposomal doxorubicin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732703 2025-02-14

MyDRUG

Multiple Myeloma Research Consortium

Phase 1/2 Completed

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡